Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Morrow

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Journal of Virology|June 17, 1998
Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2LysZ Zhang, Q Yu, S M Kang, et al.
Virus Research|September 1, 1993
Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3DpolD C Porter, D C Ansardi, M R Lentz, et al.
Vaccine|February 1, 1997
Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxinD C Porter, J Wang, Z Moldoveanu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2S Basak, S McPherson, S Kang, et al.
Journal of Virology|July 1, 1993
Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infectionD C Porter, D C Ansardi, W S Choi, et al.
Journal of Virology|April 1, 1996
Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 GagD C Porter, L R Melsen, R W Compans, et al.
International Journal of Obesity (2005)|December 8, 2016
Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF ratsT Kim, C L Holleman, T Ptacek, et al.
Virology|December 24, 1997
Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His)Y Li, Z Zhang, S M Kang, et al.
Virology|December 15, 1996
Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His)Z Zhang, S M Kang, A LeBlanc, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Primer-dependent eukaryotic RNA polymerase capable of accurate transcription from the adenovirus major late promoter in a reconstituted systemL G Fradkin, K Leong, C D Morrow, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Journal of Virology|June 17, 1998
Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2LysZ Zhang, Q Yu, S M Kang, et al.
Virus Research|September 1, 1993
Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3DpolD C Porter, D C Ansardi, M R Lentz, et al.
Vaccine|February 1, 1997
Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxinD C Porter, J Wang, Z Moldoveanu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2S Basak, S McPherson, S Kang, et al.
Journal of Virology|July 1, 1993
Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infectionD C Porter, D C Ansardi, W S Choi, et al.
Journal of Virology|April 1, 1996
Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 GagD C Porter, L R Melsen, R W Compans, et al.
International Journal of Obesity (2005)|December 8, 2016
Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF ratsT Kim, C L Holleman, T Ptacek, et al.
Virology|December 24, 1997
Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His)Y Li, Z Zhang, S M Kang, et al.
Virology|December 15, 1996
Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His)Z Zhang, S M Kang, A LeBlanc, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Primer-dependent eukaryotic RNA polymerase capable of accurate transcription from the adenovirus major late promoter in a reconstituted systemL G Fradkin, K Leong, C D Morrow, et al.
Pageof 9